Filter
42
Filtered Results: 42
Text search:
Argaw
M.
Featured
Recommendations
1
New Publications
12
Language
Document type
Studies & Reports
14
No document type
14
Guidelines
9
Strategic & Response Plan
3
Manuals
1
Training Material
1
Countries / Regions
Ethiopia
5
Indonesia
4
Global
3
Cameroon
1
Morocco
1
Guinea
1
Africa
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Côte d’Ivoire / Ivory Coast
1
Uganda
1
Angola
1
Chad
1
India
1
Authors & Publishers
Publication Years
Category
Dermatology
5
Studies & Reports
4
Humanitarian Crisis
3
Leishmaniasis
3
Buruli Ulcer
2
Snakebites
2
Parasitology
2
Hepatitis
1
Bacteriology
1
Schistosomiasis
1
COVID-19
1
Vector Control
1
Infection Control & Prevention (IPC)
1
Demograhic Health Surveys DHS
1
Policies
1
Guidelines
1
Drugs & Medical Equipment
1
NTDs & Others
1
Primary Health Care
1
Laboratory Technologies
1
Human African Trypanosomiasis
1
Disease Prevention & Control
1
Toolboxes
Community Health Workers CHW
4
Others
3
Information & Education Material (IEC)
3
NTDs General
3
Capacity Building & Resource platforms
3
Strategies & Roadmaps
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Yaws & other Endemic Treponematoses
2
Intercultural Competence
1
Policies & Strategies
1
Studies
1
Country specific documents
1
General documents One Health
1
Agriculture incl. animal husbandry
1
Antimicrobial Resistance (AMR)
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Policies & Strategies
1
Snakebite envenoming
1
General Information & Methodology
1
Women
1
Co-Morbidities (except TB)
1
One Health
1
Prevention of mother-to-child transmission (PMTCT)
1
Infection Control
1
DHS Working Papers No. 90.
Access 03.05.2017
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
Cognizant of the need for standardization of the response for COVID-19, the Federal Ministry of Health prepared this national guideline in an effort to contain the epidemic before it overwhelms the health care facilities. This national guideline is expected to guide policy makers and h...
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP ...
Ethiopia is one of the most vulnerable countries to climate change in East Africa. The future climate change projections suggest that temperature will rise and rainfall variability will increase with high unpredictability. Agriculture is extremely vulnerable to these
changes, with concerns that the...
In 2009, WHO’s Second International Conference on Buruli Ulcer Control and Research resolved to strengthen the capacity of national laboratories to confirm cases of the disease, but advised that “efforts are still needed to develop simple diagnostic tools usable in the field as well as disabilit...
In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions:
to strengthen prevention, active detection and treatment of cases of both cutaneous and visceral leishmaniasis in order to decrease the disease burde...
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive...
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim...
he road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators prese...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first ...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
La schistosomiase humaine est une maladie parasitaire chronique et aigüe causée par une infection par des douves du sang (vers trématodes) du genre Schistosoma. Cette maladie est un problème de santé publique dans les zones tropicales et
subtropicales d’Afrique, d’Asie, des Caraïbes et d...
Skin-related neglected tropical diseases, or “skin NTDs”, are historically neglected because active case detection, individual case management, significant resources and intensive effort are required to control, eliminate and eradicate them. Integrated control and management of skin NTDs offers ...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
